Prosecution Insights
Last updated: October 27, 2026

Novozymes A/S

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

70 pending office actions • 20 art units • 49 examiners • 0 of 70 (0%) have an AI response strategy ready • 65 patents granted in the last 365 days

Analysis

Novozymes A/S has 70 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 49 examiners and 20 art units, creating substantial distribution across both examination personnel and technical groups. The action total exceeds the examiner total, indicating that multiple matters are assigned to some examiners, while the 20 art units call for structured technical segmentation.

CHOWDHURY, IQBAL HOSSAIN is the busiest examiner, with 4 pending actions. That group is a useful source for identifying recurring examination positions, but it is not a substitute for reviewing the many other examiner assignments. Counsel should coordinate biotechnology claim strategy at the portfolio level while tailoring prior-art, written-description, and amendment responses to each examiner and art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

70
Total Pending OAs
47
Non-Final OAs
21
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
2
Due this week
10
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 7 days (2)Due ≤ 30 days (10)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

33
Hard (47%)
30
Medium (43%)
7
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (1%)
§101 + other11 (16%)
§103 only17 (24%)
§112 only6 (9%)
Double-patenting only1 (1%)
Double-patenting + other13 (19%)
Multi-statute (no §101)21 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

69
Life Sciences
99% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
1% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

700 h
Manual time on pending OAs
140 h
Time saved (low, 20%)
245 h
Time saved (mid, 35%)
6.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CHOWDHURY, IQBAL HOSSAIN 4 73.6% +57.6%
PAK, YONG D 4 74.7% +14.2%
HUTSON, RICHARD G 4 65.1% +52.9%
FRONDA, CHRISTIAN L 3 82.5% +14.3%
ROBINSON, HOPE A 2 67.7% +43.0%
SAIDHA, TEKCHAND 2 82.9% +14.0%
STEADMAN, DAVID J 2 57.7% +29.7%
EPSTEIN, TODD MATTHEW 2 60.8% +43.6%
LEE, JAE W 2 65.6% +38.5%
NOAKES, SUZANNE MARIE 2 73.4% +18.3%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
19019935 PROCESSES FOR PRODUCING ETHANOL FRONDA, CHRISTIAN L —
18956701 POLYPEPTIDES HAVING LYSOZYME ACTIVITY, POLYNUCLEOTIDES ENCODING SAME AND USES AND COMPOSITIONS THEREOF FRONDA, CHRISTIAN L —
18896095 STABILIZED CELLULASE VARIANTS FRONDA, CHRISTIAN L —
18826915 DETERGENT COMPOSITIONS SAIDHA, TEKCHAND —

Hard Cases (33)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18043532 PROTEASE VARIANTS WITH IMPROVED SOLUBILITY PAK, YONG D 81d overdue
17764491 USE OF CELLULASE FOR IMPROVEMENT OF SUSTAINABILITY OF DETERGENTS HURST, JONATHAN M 58d overdue
18042282 VARIANTS OF A FAMILY 44 XYLOGLUCANASE PAK, YONG D 23d overdue
17913103 CLEANING COMPOSITIONS COMPRISING POLYPEPTIDES HAVING FRUCTAN DEGRADING ACTIVITY FAN, LYNN Y 17d overdue
17778452 POLYPEPTIDES HAVING PROTEOLYTIC ACTIVITY AND USE THEREOF XU, QING 16d overdue
18389518 Subtilase Variants and Compositions Comprising Same HUTSON, RICHARD G 2d overdue
18570301 METHOD FOR CONTROLLING SLIME IN A PULP OR PAPER MAKING PROCESS PAK, YONG D 1d overdue
17762689 DEOXYRIBONUCLEASE USES IN DETERGENT COMPOSITION KOLB, KATARZYNA I 14d

Interview Candidates (27)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18052489 PROTEASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME EPSTEIN, TODD MATTHEW 87d overdue
18043532 PROTEASE VARIANTS WITH IMPROVED SOLUBILITY PAK, YONG D 81d overdue
18043515 POLYESTER DEGRADING PROTEASE VARIANTS HUTSON, RICHARD G 71d overdue
17927164 SUBTILASE VARIANTS AND COMPOSITIONS COMPRISING SAME LEE, JAE W 70d overdue
18042282 VARIANTS OF A FAMILY 44 XYLOGLUCANASE PAK, YONG D 23d overdue
18389518 Subtilase Variants and Compositions Comprising Same HUTSON, RICHARD G 2d overdue
18570301 METHOD FOR CONTROLLING SLIME IN A PULP OR PAPER MAKING PROCESS PAK, YONG D 1d overdue
18547525 DNASE VARIANTS HUTSON, RICHARD G 12d

Top Art Units

Art UnitApps
1652 19
1656 13
1657 6
1799 5
1653 4
1793 3
1792 3
1761 2
1651 2
1759 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19032682 Counter-Selection by Inhibition of Conditionally Essential Genes COLLINS, CYNTHIA E 1662 §103DP Non-Final OA — Pending Jan 21, 2025
19019935 PROCESSES FOR PRODUCING ETHANOL FRONDA, CHRISTIAN L 1652 §103§112DP Non-Final OA — Pending Jan 14, 2025
18871339 MEANS AND METHODS FOR REDUCING PHOSPHORUS SECRETION BY FISH ROBINSON, HOPE A 1652 §101§102§112 Non-Final OA — Pending Dec 03, 2024
18956701 POLYPEPTIDES HAVING LYSOZYME ACTIVITY, POLYNUCLEOTIDES ENCODING SAME AND USES AND COMPOSITIONS THEREOF FRONDA, CHRISTIAN L 1652 §112Other Non-Final OA — Pending Nov 22, 2024
18859642 BREWING WITH THERMOSTABLE AMG VARIANTS LI, CHANGQING 1791 §102§103§112 Non-Final OA — Pending Oct 24, 2024
18857409 PROCESS FOR PRODUCING FREE FATTY ACIDS ROBINSON, HOPE A 1652 §102§112 Non-Final OA — Pending Oct 16, 2024
18857436 PRODUCTION OF FATTY ACID ALKYL ESTERS CHOWDHURY, IQBAL HOSSAIN 1656 §102§103§112 Non-Final OA — Pending Oct 16, 2024
18909608 Manganese Bleach Catalyst Granules DELCOTTO, GREGORY R 1761 §103 Non-Final OA — Pending Oct 08, 2024
18896095 STABILIZED CELLULASE VARIANTS FRONDA, CHRISTIAN L 1652 §103§112DP Non-Final OA — Pending Sep 25, 2024
18826915 DETERGENT COMPOSITIONS SAIDHA, TEKCHAND 1652 §102§103§112DP Final Rejection — Pending Sep 06, 2024
18822802 POLYPEPTIDES PAK, YONG D — §101§103§112 Non-Final OA — Pending Sep 03, 2024
18840367 PROCESS FOR PRODUCING FERMENTATION PRODUCTS AND BIOGAS FROM STARCH-CONTAINING MATERIALS RAGHU, GANAPATHIRAM 1652 §103§112DP Non-Final OA — Pending Aug 21, 2024
18840008 METHOD FOR CARRYING OUT THE COMBINED OPERATION OF A BIOETHANOL PRODUCTION UNIT AND A BIOGAS UNIT GORDON, MELENIE LEE 1651 §102§112 Non-Final OA — Pending Aug 20, 2024
18832145 DNase Variants and Compositions STEADMAN, DAVID J 1656 §103§112DP Non-Final OA — Pending Jul 23, 2024
18726653 METHOD FOR PROVIDING RELIEF FROM FRUCTAN OR FRUCTOSE INDUCED ABDOMINAL DISCOMFORT EDWARDS, JESSICA FAYE 1657 §101§102§103§112 Non-Final OA — Pending Jul 03, 2024
18723211 REDUCTION OF RESIDUAL DNA IN MICROBIAL FERMENTATION PRODUCTS TSAY, MARSHA M 1656 §101§103 Final Rejection — Pending Jun 21, 2024
18720981 COMPOSITION COMPRISING A LIPASE AND A BOOSTER BOWERS, NATHAN ANDREW 1799 §102§103§112 Non-Final OA — Pending Jun 17, 2024
18719062 METHODS AND USES FOR IMPROVING EGG PRODUCTION AND EGG QUALITY INVOLVING ADMINISTERING FEED COMPRISING MURAMIDASE GLIMM, CARRIE LYNN STOFFEL 1793 §102§103§112DP Non-Final OA — Pending Jun 12, 2024
18716115 IMPROVED PROTEIN PRODUCTION IN RECOMBINANT BACTERIA SAIDHA, TEKCHAND 1652 §102§112 Non-Final OA — Pending Jun 03, 2024
18675391 Phytase Variants and Polynucleotides Encoding Same MEAH, MOHAMMAD Y 1652 §103§112 Non-Final OA — Pending May 28, 2024
18700134 ENDOGLUCANASE WITH IMPROVED STABILITY BOWERS, ERIN M 1653 §103§112 Non-Final OA — Pending Apr 10, 2024
18607109 CELLOBIOHYDROLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME EPSTEIN, TODD MATTHEW 1652 §101§102Other Final Rejection 20d Pending Mar 15, 2024
18601534 ALPHA-AMYLASE VARIANTS LEE, JAE W 1656 §102§112DP Non-Final OA — Pending Mar 11, 2024
18685684 FRAGRANCE BEAD COMPOSITION AND USE THEREOF LOUNTOS, GEORGE THEMISTOCLIS 1652 §102§103§112Other Non-Final OA — Pending Feb 22, 2024
18443755 EJECTOR EQUIPPED FERMENTER HOBBS, MICHAEL L 1799 §103 Non-Final OA — Pending Feb 16, 2024
18571661 RECOMBINANT CUTINASE EXPRESSION YAMASAKI, ROBERT J 1657 §112 Final Rejection 23d overdue Pending Dec 18, 2023
18570301 METHOD FOR CONTROLLING SLIME IN A PULP OR PAPER MAKING PROCESS PAK, YONG D 1652 §103§112 Final Rejection 1d overdue Pending Dec 14, 2023
18389518 Subtilase Variants and Compositions Comprising Same HUTSON, RICHARD G 1652 §102§103Other Final Rejection 2d overdue Pending Nov 14, 2023
18557507 DETERGENT COMPOSITION WITH REDUCED POLYMER CONTENT CHOWDHURY, IQBAL HOSSAIN 1656 §101§102§112 Non-Final OA — Pending Oct 26, 2023
18547679 Polypeptide Variants MOEHLMAN, ANDREW TERRY 1655 §103Other Final Rejection 7d Pending Aug 23, 2023
18547525 DNASE VARIANTS HUTSON, RICHARD G 1652 §103 Non-Final OA 12d Pending Aug 23, 2023
18546866 METHOD OF IMPROVING CARBOHYDRATE DIGESTIBILITY BY A CARBOHYDRATASE IN AN ANIMAL FEED BY EMPLOYING SERINE PROTEASE SHELLHAMMER, JAMES PAUL 1793 §103 Final Rejection 15d overdue Pending Aug 17, 2023
18263809 METHODS OF SELECTIVELY PROMOTING ANIMAL WELFARE THROUGH MODULATION OF MICROBIOME MUKHOPADHYAY, BHASKAR 1792 §103 Non-Final OA — Pending Aug 01, 2023
18263818 METHODS FOR REDUCING PATHOGENIC E COLI BY SELECTIVE FEED ADDITIVE INTERVENTION COMPRISING ENZYMES SUCH AS MURAMIDASE PAGUIO FRISING, MICHELLE F 1651 §103 Final Rejection — Pending Aug 01, 2023
18263339 ALPHA-AMYLASE VARIANTS HUTSON, RICHARD G 1652 §102DP Final Rejection — Pending Jul 27, 2023
18262619 STABILIZED BIOLOGICAL DETERGENTS TUCKER, PHILIP C 1745 §103 Non-Final OA 27d Pending Jul 24, 2023
18262051 LIPASE WITH LOW MALODOR GENERATION NOAKES, SUZANNE MARIE 1799 §102§103§112 Non-Final OA — Pending Jul 19, 2023
18257665 IMPROVED FIBER-WASH IN CORN WET-MILLING CHOWDHURY, IQBAL HOSSAIN 1656 §102§103§112 Final Rejection — Pending Jun 15, 2023
18318442 DETERGENT COMPOSITION COMPRISING LACCASE STEADMAN, DAVID J 1656 §101§102§103§112Other Non-Final OA 16d Pending May 16, 2023
18251533 LEADER PEPTIDES AND POLYNUCLEOTIDES ENCODING THE SAME ZINGARELLI, SANDRA 1653 §112 Final Rejection 14d Pending May 02, 2023
18034559 USE OF LIPOXYGENASE KIPOUROS, HOLLY MICHAELA 1799 §103 Non-Final OA — Pending Apr 28, 2023
18250397 Baked and Par-Baked Products with Thermostable AMG Variants from Penicillium DIVIESTI, KARLA ISOBEL 1792 §103 Non-Final OA — Pending Apr 25, 2023
18249826 METHOD FOR PERFORMANCE EVALUATION OF A DETERGENT COMPOSITION BEVERIDGE, CONNOR HAMMOND 1687 §101§103§112 Non-Final OA — Pending Apr 20, 2023
18249231 LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS CHOWDHURY, IQBAL HOSSAIN 1656 §102§112 Non-Final OA 28d Pending Apr 14, 2023
18249037 GLYCOSYLTRANSFERASE VARIANTS FOR IMPROVED PROTEIN PRODUCTION POPA, ILEANA 1633 §112 Final Rejection — Pending Apr 13, 2023
18029590 New Granules for Animal Feed PAPCIAK, SHARON M 1657 §103 Final Rejection 6d Pending Mar 30, 2023
18029594 Enzymatic Preservation of Probiotics in Animal Feed TURNER, FELICIA C 1793 §103 Non-Final OA 29d Pending Mar 30, 2023
18043515 POLYESTER DEGRADING PROTEASE VARIANTS HUTSON, RICHARD G 1652 §112 Final Rejection 71d overdue Pending Feb 28, 2023
18043532 PROTEASE VARIANTS WITH IMPROVED SOLUBILITY PAK, YONG D 1652 §101§102§103§112DP Final Rejection 81d overdue Pending Feb 28, 2023
18042282 VARIANTS OF A FAMILY 44 XYLOGLUCANASE PAK, YONG D 1652 §102§103 Non-Final OA 23d overdue Pending Feb 20, 2023

View all 70 →

Managing Novozymes A/S's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Novozymes A/S have?

Novozymes A/S has 70 pending office actions as of October 2026, spread across 20 art units and 49 examiners.

Which USPTO examiner handles the most Novozymes A/S applications?

Iqbal Hossain Chowdhury has the most, with 4 of Novozymes A/S's pending office actions.

What technology area are Novozymes A/S's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month